Rod Dashwood

Professor, Texas A&M University
  • Texas A&M University
  • United States of America

About Rod Dashwood

Roderick H. Dashwood, Ph.D., FRSB | Director, Center for Epigenetics & Disease Prevention, Texas A&M Health, 2121 W. Holcombe Blvd., Houston, TX 77030; John S. Dunn Chair for Disease Prevention; Professor, Dept. Translational Medical Sciences, Texas A&M School of Medicine.


Cancer Biology Cancer Models Cell Signaling Drug Repurposing Oncogenes Prevention


Channels contributed to:

Behind the Paper

Recent Comments

Mar 27, 2023

Supplementary figures | Constitutive expression of ACE2 in human colon cancer cells; ACE2 regulates DNA repair, cell viability and apoptosis in SW480 and SW620 human colon cancer cells; forced expression of ACE2 increases endogenous BRD4 and c-Myc in SW480 cells; BET inhibitors and degraders lower endogenous ACE2 and c-Myc expression in human colon cancer cells; ACE2 overexpression in rat colon adenomas; gating strategies for cell sorting via FACS.

Mar 11, 2023

Current contact information:

Dr. Shilan Zhang,

Department of Cardiovascular Medicine,

Shanghai Tenth People's Hospital,

Tongji University School of Medicine.


Mar 10, 2023

Current contact information:

Dr. Chakrapani Tripathi, Senior Scientist 

Nektar Therapeutic,

455 Mission Bay Boulevard South,

San Francisco, CA 94158.


Phone: 3179353701

Mar 07, 2023

Acknowledgements | Nivedhitha Mohan provided initial drafts of the text and associated artwork, and was a major contributor to the blog, along with further edits by other coauthors, in particular, Dr. Praveen Rajendran.